Advancing Patient Safety Through Prescription Drug Monitoring Programs

This white paper outlines the role of Prescription Drug Monitoring Programs (PDMPs) in enhancing patient safety amid the opioid epidemic. PDMPs provide essential data on controlled substance prescriptions, enabling healthcare providers to identify patients at risk for substance use disorders. The paper discusses how PDMPs facilitate early intervention and informed treatment decisions, thereby improving patient outcomes. It highlights the integration of real-time data sharing and electronic health record (EHR) systems, which enhance the accessibility and utility of PDMP data for clinicians. Additionally, the document details the benefits of comprehensive PDMP utilization, including the incorporation of nonfatal overdose data and proactive decision support for prescribers. The white paper also emphasizes the importance of collaboration among state governments, healthcare professionals, and technology experts to maximize the effectiveness of PDMPs. Strategies such as Medication for Opioid Use Disorder (MOUD) prompts and naloxone co-prescription alerts are presented as innovative approaches to further support patient safety and combat substance misuse.